Cargando…
Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution
Individuals with glucocorticoid-induced osteoporosis experience vertebral fractures at an increased rate and at higher vertebral areal bone mineral density (aBMD) than individuals with primary osteoporosis. Standard posteroanterior- (PA-) projection dual energy X-ray absorptiometry (DXA) lacks the d...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662195/ https://www.ncbi.nlm.nih.gov/pubmed/23737778 http://dx.doi.org/10.1155/2013/768579 |
_version_ | 1782270820274405376 |
---|---|
author | Manning, Louise I. Briggs, Andrew M. Van Doornum, Sharon Kale, Ashwini Kantor, Susan Wark, John D. |
author_facet | Manning, Louise I. Briggs, Andrew M. Van Doornum, Sharon Kale, Ashwini Kantor, Susan Wark, John D. |
author_sort | Manning, Louise I. |
collection | PubMed |
description | Individuals with glucocorticoid-induced osteoporosis experience vertebral fractures at an increased rate and at higher vertebral areal bone mineral density (aBMD) than individuals with primary osteoporosis. Standard posteroanterior- (PA-) projection dual energy X-ray absorptiometry (DXA) lacks the diagnostic sensitivity required for reliable estimation of vertebral fracture risk in individuals. Assessment of subregional vertebral aBMD using lateral-projection DXA may improve the predictive value of DXA parameters for fracture. One hundred and four individuals were recruited and grouped for this study: primary osteoporosis with no history of vertebral fracture (n = 43), glucocorticoid-induced bone loss (n = 13), and healthy controls (n = 48). Standard PA-projection and supine-lateral scans were performed, and lateral scans were analysed according to an established protocol to measure aBMD within 6 subregions. Main effects for subregion and group were assessed and observed, by ANCOVA. Ratios were calculated between subregions and compared between groups, to overcome the potentially confounding influence of variability in subregional geometry. Significantly lower values were observed in the glucocorticoid group for the ratios of (i) anterior subregion: whole vertebral body and (ii) posterior: whole vertebral body when compared to the primary osteoporosis and control groups (P < 0.05). Lower anterior subregional aBMD in individuals on glucocorticoid therapy may help to explain the increased vertebral fracture risk in this patient group. |
format | Online Article Text |
id | pubmed-3662195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36621952013-06-04 Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution Manning, Louise I. Briggs, Andrew M. Van Doornum, Sharon Kale, Ashwini Kantor, Susan Wark, John D. Int J Endocrinol Research Article Individuals with glucocorticoid-induced osteoporosis experience vertebral fractures at an increased rate and at higher vertebral areal bone mineral density (aBMD) than individuals with primary osteoporosis. Standard posteroanterior- (PA-) projection dual energy X-ray absorptiometry (DXA) lacks the diagnostic sensitivity required for reliable estimation of vertebral fracture risk in individuals. Assessment of subregional vertebral aBMD using lateral-projection DXA may improve the predictive value of DXA parameters for fracture. One hundred and four individuals were recruited and grouped for this study: primary osteoporosis with no history of vertebral fracture (n = 43), glucocorticoid-induced bone loss (n = 13), and healthy controls (n = 48). Standard PA-projection and supine-lateral scans were performed, and lateral scans were analysed according to an established protocol to measure aBMD within 6 subregions. Main effects for subregion and group were assessed and observed, by ANCOVA. Ratios were calculated between subregions and compared between groups, to overcome the potentially confounding influence of variability in subregional geometry. Significantly lower values were observed in the glucocorticoid group for the ratios of (i) anterior subregion: whole vertebral body and (ii) posterior: whole vertebral body when compared to the primary osteoporosis and control groups (P < 0.05). Lower anterior subregional aBMD in individuals on glucocorticoid therapy may help to explain the increased vertebral fracture risk in this patient group. Hindawi Publishing Corporation 2013 2013-05-08 /pmc/articles/PMC3662195/ /pubmed/23737778 http://dx.doi.org/10.1155/2013/768579 Text en Copyright © 2013 Louise I. Manning et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Manning, Louise I. Briggs, Andrew M. Van Doornum, Sharon Kale, Ashwini Kantor, Susan Wark, John D. Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution |
title | Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution |
title_full | Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution |
title_fullStr | Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution |
title_full_unstemmed | Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution |
title_short | Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution |
title_sort | glucocorticoid-induced bone loss is associated with abnormal intravertebral areal bone mineral density distribution |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662195/ https://www.ncbi.nlm.nih.gov/pubmed/23737778 http://dx.doi.org/10.1155/2013/768579 |
work_keys_str_mv | AT manninglouisei glucocorticoidinducedbonelossisassociatedwithabnormalintravertebralarealbonemineraldensitydistribution AT briggsandrewm glucocorticoidinducedbonelossisassociatedwithabnormalintravertebralarealbonemineraldensitydistribution AT vandoornumsharon glucocorticoidinducedbonelossisassociatedwithabnormalintravertebralarealbonemineraldensitydistribution AT kaleashwini glucocorticoidinducedbonelossisassociatedwithabnormalintravertebralarealbonemineraldensitydistribution AT kantorsusan glucocorticoidinducedbonelossisassociatedwithabnormalintravertebralarealbonemineraldensitydistribution AT warkjohnd glucocorticoidinducedbonelossisassociatedwithabnormalintravertebralarealbonemineraldensitydistribution |